ifosfamide
information and resources from the National Cancer Institute
IFEX
Third line chemotherapy of germ cell testicular cancer when used in combination with certain other approved antineoplastic agents.
Bristol-Myers Squibb Dec 30 1988
|
|
|
|
news articles
ICE Plus CAV Intensification Promising for High Risk Ewing’s ... Mar 31, 2006
Cancer Consultants (press release), Researchers from Italy have reported that an induction regimen of ifosfamide, carboplatin and etoposide (ICE) followed by intensification with cyclophosphamide ...
First patient treated in phase 1/2 trial with alkylating drug in ... Mar 28, 2006
Therapeutics Daily (subscription) (press release), ZIO-201 (isophosphoramide mustard or IPM) is the active metabolite of ifosfamide, a frequently used treatment for sarcoma. Due to ...
Ziopharm presents preclinical kidney toxicity data on metabolite ... Mar 23, 2006
Therapeutics Daily (subscription) (press release), Ziopharm Oncology, Inc. (ZIOP) presented preclinical data showing ZIO-201, the active metabolite of ifosfamide, may be less likely to kill normal kidney cells ...
Updated Guidelines for Treatment of Ovarian Cancer Mar 27, 2006
Cancer Consultants (press release), ...recurrent ovarian cancer was broadened to include Arimidex® (anastrozole), Avastin® (bevacizumab), Camptosar® (ironotecan), Ifex® (ifosfamide), and Femara ...
Neoadjuvant Sarcoma Chemotherapy Results in High Toxicity Levels Mar 1, 2006
Cancerpage.com, The patients received three cycles of neoadjuvant modified mesna, doxorubicin, ifosfamide and dacarbazine (MAID), interdigitated radiotherapy and following ...
Gleevec Has Activity for Treatment of Aggressive Fibromatosis Mar 20, 2006
Cancer Consultants (press release), ...mg/day). Thirteen of these patients had failed prior chemotherapy regimens usually containing anthracyclines and ifosfamide. They ...
NCCN Announces Important Updates to Ovarian Cancer Clinical ... Mar 6, 2006
Genetic Engineering News, ...for ovarian cancer to include anastrazole (Arimidex, AstraZeneca), bevacizumab (Avastin, Genentech), irinotecan (Camptosar, Pfizer), ifosfamide (Ifex, Bristol ...
Neoadjuvant Chemotherapy and Radiotherapy Promising for Large Soft ... Mar 3, 2006
Cancer Consultants (press release), All were scheduled to receive neoadjuvant concomitant radiotherapy and chemotherapy with MAID (mesna, ifosfamide, doxorubicin and dacarbazine). ...
PharmaMar Confirms Intention to Submit MAA Dec 19, 2005
APA OTS (Pressemitteilung), 24hr) in patients with previously treated, advanced or metastatic STS, who have failed to respond to standard STS chemotherapy, doxorubicine and ifosfamide. ...
ZIOPHARM Oncology Announces ZIO-201 ASH Abstract Publication Nov 21, 2005
Business Wire (press release), In abstract 4727 titled "Isophosphoramide Mustard-lysine (ZIO-201): Active Moiety of Ifosfamide (IFOS) without Kidney Toxicity," by Mary Taub and coworkers at ...
Survival rate still poor when bone cancer returns Dec 2, 2005
Reuters.uk, ..."The probability for long-term disease-free survival," he added, "may be enhanced by the use of high-dose ifosfamide" after surgery. ...
|
|
